Researchers reviewed key design considerations for CRISPR-based epigenetic editing, focusing on how to achieve targeted regulation without relying on double-stranded DNA breaks. The review highlights practical uncertainties around tool selection, guide RNA and effector combinations, timing, cell-type suitability, and durability—particularly given the growing catalog of distinct dCas9-based constructs available through Addgene.